Maryland Social Equity Dispensaries Slowly Open as State Eases Rules

Maryland has awarded 83 social equity dispensary licenses since 2023, yet only 17 are open for business — a figure that has doubled since the start of the year as operators finally clear the financing gaps, zoning disputes, and reluctant landlords that kept most of those licenses dormant.

Recreational sales have been legal in the state since July 2023, and Maryland now runs one of the busier retail markets on the East Coast. The Cannabis Reform Act that legalized those sales also created a social equity program and, like equity efforts in states such as Illinois, reserved a licensing round for applicants from communities hit hardest by prohibition. Those licenses have proved far harder to turn into operating storefronts than the ones held by established medical operators, most of which simply converted to sell adult-use product alongside medical. Ninety-nine non-social-equity dispensaries are currently open, according to Maryland Cannabis Administration data, against the 17 equity shops now trading.

A licensing structure that limits capital

The central constraint is how the equity license itself is built. To qualify, an applicant had to hold at least 65 percent ownership and control, and the Cannabis Administration read that to mean the equity owner keeps near-total control — the authority to make every substantive decision without a partner’s sign-off. The rule guards the program’s intent, but it also caps how much governance an outside investor can negotiate, which in turn caps how much capital an equity licensee can raise.

Operators describe that as the line between opening and stalling. The multi-state operators they compete with arrived with balance sheets, real estate relationships, and vendor contacts that a self-financed first-time owner cannot match, the same resource gap now visible as those chains expand store networks in neighboring markets. Keeping the licenses in local hands, rather than letting better-capitalized operators absorb them, was the point of the round.

A state law that took effect July 1, 2026 is meant to ease that squeeze. The measure, signed by Governor Wes Moore on May 12, 2026, lowers the minimum equity-ownership threshold from 65 to 55 percent, widening the slice an outside investor can hold, and points toward letting a licensee’s control rights track their ownership share rather than stay absolute. It also expands the signage a dispensary may post at its storefront and loosens an advertising-audience rule operators had lobbied against with little prior success. How much it changes deal terms depends on how the Cannabis Administration interprets the new standard, which has not yet happened.

Zoning fights and real estate stigma

Location has been its own obstacle. Candice Peters, a physician who first sought a license more than a decade ago when Maryland legalized medical use, opened Coastal Cure Cannabis in Delmar on June 1, 2026, roughly two years after winning her license. Others have hit harder walls. Frank Hayes and co-owner Felicia Covel Rami were converting a former bank in Kensington into Crabtree Dispensary when the state halted the work after two nearby churches complained, citing a rule that keeps dispensaries at least 500 feet from a place of worship. The churches themselves turned out to lack permits and had to relocate, and the stop-work order was lifted only after the owners sued. Crabtree opened April 14, 2026.

Even a compliant site can be hard to land. Operators say many landlords, or their anchor tenants, still refuse to share a building with a cannabis retailer, a reluctance rooted in the drug’s continued federal illegality. It is the same stigma other states are now legislating around, as when Delaware overrode a veto to curb county zoning limits on dispensaries. For a first-time equity owner, it makes site selection slower and more expensive than the zoning map alone suggests.

Federal uncertainty on the adult-use side

The federal picture grew more complicated in the spring. Acting Attorney General Todd Blanche moved FDA-approved cannabis products and state-licensed medical marijuana to Schedule III effective April 28, 2026, putting medical cannabis on par with drugs like ketamine in federal eyes. The order pointedly left recreational marijuana in Schedule I, so the adult-use side of a Maryland dispensary — the bulk of its sales — stays federally illegal.

That split has scrambled compliance decisions on the ground. The reclassification opened an expedited path for state medical licensees to register with the Drug Enforcement Administration, and registered businesses cannot transact with unregistered partners, so a supplier’s choice can force a dispensary’s hand. Some licensees have registered; others have held back. “If anything, this April decision has just created a lot of confusion,” Hayes told Maryland Matters, saying neither camp feels confident about the path forward. For owners who came up through the war on drugs the program is meant to redress, the decision is personal as much as procedural: the DEA is the same agency that once drove enforcement, and handing it business records is not a neutral act.

Demand is not the problem. Maryland’s combined medical and adult-use sales have topped $3.46 billion since 2023 and set fresh monthly records this year, even as the national market contracts under oversupply and price compression. The open question is whether the equity licensees the program was built for can raise the capital and clear the federal fog fast enough to claim a share of it.